Anthony Cerami, PhD
Chief Executive Officer
Chairman of the Board of Directors
Member, Scientific Advisory Board
Anthony Cerami, PhD is the founder of Warren Pharmaceuticals, Inc. and serves as its Chairman of the Board and CEO.
A member of the National Academy of Sciences and former dean of The Rockefeller University, Dr. Cerami has had a successful career applying detailed biochemical insights to the design of novel therapeutic strategies, translating scientific discovery into commercially viable products of high clinical utility.
He received his PhD from The Rockefeller University in 1967 and completed postdoctoral fellowships at Harvard Medical School and at the Jackson Laboratory in Bar Harbor, Maine. Dr. Cerami served 20 years as Professor and Head of the Laboratory of Medical Biochemistry and as Dean of Graduate and Post Graduate Studies of Rockefeller University.
He established the Picower Institute for Medical Research in Manhasset, New York, in July 1991 and became its first president. He is a recipient of a number of awards, including the Luft Award in Diabetes, and the Banting Medal for Scientific Achievement, awarded by the American Diabetes Association in recognition of his lifelong work on diabetes.
Dr. Cerami has been the inventor or co-inventor on over 150 issued U.S. patents and hundreds of foreign counterparts. He is the author or co-author of over 500 scientific publications, and is the co-inventor of the anti-TNF monoclonal antibody that has been approved by the FDA for the treatment of Crohn's disease and rheumatoid arthritis.
Dr. Cerami is also the inventor of the hemoglobin A1c test that is used by diabetics worldwide.